{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-040034","form_type":"8-K","ticker":"MDT","cik":"0001613103","company_name":"Medtronic plc","filed_at":"2026-06-03T10:47:08+00:00","discovered_at":"2026-06-03T10:50:00.303611+00:00","generated_at":"2026-06-03T10:50:45.575341+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Medtronic Q4 rev $9.8B (+6.6% organic), non-GAAP EPS $1.55; dividend raised to $0.72","bullets":["Q4 revenue $9.807B, +9.9% reported / +6.6% organic; GAAP EPS $0.96, non-GAAP EPS $1.55.","FY26 revenue $36.364B, +8.4% reported / +5.8% organic; GAAP EPS $3.73, non-GAAP EPS $5.53.","Dividend increased to $0.72/quarter ($2.88 annual), payable July 17, 2026; 49th consecutive annual increase.","FY27 guidance: organic revenue growth 6.75%-7.25%, non-GAAP EPS $5.90-$6.00.","Cardiac Ablation Solutions revenue +78% globally; Hugo RAS submission filed with FDA for general surgery/gyn."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-040034","json":"https://secwatch.observer/filing/0001628280-26-040034.json","markdown":"https://secwatch.observer/filing/0001628280-26-040034.md","text":"https://secwatch.observer/filing/0001628280-26-040034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1613103/000162828026040034/0001628280-26-040034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1613103/000162828026040034/mdt-20260603.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T10:50:45.575341+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"99d97fce84a36cfb78b6f4e40d050cc6dfe70552","claim":"Medtronic plc reported financial results for fourth quarter (Q4) and fiscal year 2026 (FY26), which ended April 24, 2026.","evidence_excerpt":"On June 03, 2026, Medtronic plc, a public limited company organized under the laws of Ireland, issued a press release announcing its full year and fourth quarter and fiscal year 2026 financial results.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1613103/000162828026040034/0001628280-26-040034-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter (Q4) and fiscal year 2026 (FY26), which ended April 24, 2026"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}